个人简介从事肿瘤临床10余年，擅长临床常见肿瘤的综合治疗，尤其是良恶性肿瘤的放射治疗。主持和参与多项国家级及省级科研项目，近年来发布论文7篇，其中SCI文章5篇。 擅长宫颈癌、肺癌、乳腺癌、鼻咽癌及脑瘤等的放疗、化疗、免疫、中成药、生物治疗等多种抗肿瘤治疗手段。 学术任职广东省医学会放射肿瘤学分会青年委员会 青年委员主研方向恶性肿瘤的放射治疗、综合治疗获奖情况 ① zhenhua yang , ying liu1, changzheng shi, yuqin zhang, rongzhao lv, rong zhang, qian wang and yiming wang.Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways.ONCOLOGY REPORTS,2017. 37: 1011-1019. ② 刘瑛, 张余琴, 杨振华, 张荣, 王倩, 王奕鸣.同步推量调强放疗联合化疗治疗局部中晚期宫颈癌的疗效和安全性. 肿瘤，2017; 37（9）:974-981. ③ 刘瑛, 李丽莎,谢逢安,刘玉瑶,王奕鸣.医用射线防护剂可减轻头颈部鳞癌患者的放疗皮肤损伤.南方医科大学学报，2016；36（3）:443-444. ④ Liu Y, Shi C, Cui M, Yang Z, Gan D, Wang Y. Different doses of partial liver irradiation promotes hepatic regeneration in rat. Int J Clin Exp Pathol. 2015, 8(6):6554-9. ⑤ Liu Y, He S, Ding Y, Huang J, Zhang Y, Chen L. The efficacy and safety of thalidomide-based therapy in patients with advanced non-small cell lung cancer: a meta-analysis. Contemp Oncol(Pozn). 2014; 18(1): 39-47. ⑥ Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan J, Li Q, Zhang Y, Ding Y, Chen B, Chen L.MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1. PloS One. 2014; 9(2): e88893. doi: 10.1371. ⑦Xiao J, Ding Y, Huang J, Liu Y, Li Q, Zheng X, Zhang Y, Zhu Y, Chen L, Chen B. The association of HMGB1 gene with the prognosis of HCC. PloS One. 2014; 9(2): e89097. doi: 10.1371.学术论著[收起]